Earnings Call with Investors / Analysts at on Thursday, the 29th May 2025 at 11:00 AM IST to discuss the Audited Financial Results of the Company for the quarter and year ended 31st March, 2025

pdf

Natco Pharma Ltd.

12 May 2025

878.80

1.10%

Board Meeting

Natco Pharma Ltd - 524816 - Board Meeting Intimation for Audited Financial Results For The Quarter …

BSE India

Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 ,inter alia, to consider and approve Audited Financial Results for the quarter and year ended 31st March, 2025

pdf

Natco Pharma Ltd.

19 Apr 2025

878.80

1.10%

Company Update

Natco Pharma Ltd - 524816 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018

pdf

Natco Pharma Ltd.

09 Apr 2025

878.80

1.10%

Corp. Note

Natco Pharma Ltd - 524816 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyNatco Pharma Ltd 2CIN NO.L24230TG1981PLC003201 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY AA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)ICRA LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkNSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: CH VENKAT RAMESH Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER EmailId: venkatramesh.ch@natcopharma.co.in Name of the Chief Financial Officer: S V V N APPA RAO Designation: CHIEF FINANCIAL OFFICER EmailId: svvn@natcopharma.co.in Date: 09/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf